Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.305 USD | -7.45% | -19.25% | -42.22% |
13/05 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
09/05 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.22% | 96.25M | |
+45.30% | 56.69B | |
-2.85% | 41B | |
+38.08% | 38.11B | |
-11.22% | 26.89B | |
+16.26% | 25.59B | |
-22.28% | 18.59B | |
+0.03% | 12.39B | |
+26.26% | 11.99B | |
+22.80% | 11.88B |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating